The best strains we have for
a H1N1 swine flu vaccine grow only as half as fast as ordinary vaccine viruses, meaning poorer nations may not get it in time if there is a second wave
Not exact matches
The
vaccine's effectiveness suggests there must be pre-existing cell - mediated immunity, possibly because of similarities between the surface proteins on
swine flu and the seasonal
H1N1 flu that emerged in 1977.
Treatment plans are shaken by the discovery of
swine flu that is resistant to the antiviral drug Tamiflu and the realisation that the
H1N1 vaccine is growing only half as fast as the ordinary
flu vaccine.
The chief
flu scientist at the World Health Organization (WHO) today defended his agency against criticism that the
H1N1 swine flu pandemic was «fake,» that its threat to human health was hyped, and that WHO's policies were influenced by
vaccine manufacturers who benefited from the pandemic virus.
Novartis announced in a press statement today that it has made the first batch of
vaccine against the A (
H1N1) influenza virus causing the
swine flu pandemic.
Although the world's attention is focused on the novel
H1N1 virus causing the
swine flu pandemic, H3N2, a seasonal strain of influenza, has popped up in many East Asian countries — and some variants in circulation may outfox the seasonal
vaccine in use.
That's because the
vaccine debate crystallized in 2009 - 2010 when media hype created a pandemic leading to mass inoculation against
H1N1 (
swine flu) that passed as weirdly as it arrived... By 2010, savvy dog breeders were rethinking
vaccine protocol and the public said «no way» to that year's drugstore signs «get your
flu shots here» See display links.
It is now predicting a 70 percent likelihood that there will not be enough
H1N1 vaccine available to hit government targets until at least December, and a a more than 90 percent probability that more than half of U.S.
flu cases this season will be
swine flu.